Ally Bridge Group is a global healthcare manager focused on high-impact life science innovation across private and public markets. Founded in 2013 by Frank Yu, Co-Chief Executive Officer and Co-Chief Investment Officer, the firm manages assets from offices in New York and Hong Kong. Our mission is to generate superior risk-adjusted returns for investors while seeking to address unmet medical needs. We aim to achieve this by blending deep scientific and clinical research with financial and capital markets expertise.

Ally Bridge Group

Viewport Meta

IPhone / Mobile Compatible

SSL by Default

Euro

Google Tag Manager

HSTS

Google Font API

Google Analytics

WordPress

Chief Financial Officer

Daniel Johnson

Owner

Jihan Liu

President/Co-Owner

Leslie Meyer

CFO/Co-Owner

Paul Dymarkowski

Head of Operations

Eric Kwong

Vice President

Tinnie Chau

Managing Director

Kevin Reilly

Consulting

Luke Li

Portfolio Manager, MedAlpha Fund

Slanix Alex

Sales and Support

Amy (Klein) Herrup

Tom Boone

Venture Partner

Charles Chon

Arthur Kuan

Founding Member

Mattan Lurie

Frank Yu

Founder and CEO

David Nikodem

Dayu Teng

Ceribell focuses on making electroencephalography accessible, efficient, and cost-effective.

Grail is a healthcare company that develops pan-cancer screening tests designed to detect cancers at an early stage.

Nautilus Biotechnology offers a high-throughput, low-cost platform for analyzing and quantifying the human proteome.

Skye Bioscience is a pharmaceutical company developing new therapeutic outcomes for diseases.

Sagimet Biosciences is a biotechnology company that focuses on developing novel therapeutics to treat important diseases.

CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.

Cerevel Therapeutics is a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric disorders.

Alumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.

Context Therapeutics is a  clinical-stage biopharmaceutical company.

Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.

Venture Stage Investors with Investments in New England

Venture Stage Investors with Investments in Greater New York Area

Investors Active in Midwestern US

Late Stage Venture Investors with Investments in New England

Ally Bridge Group is a healthcare-focused investment group committed to venture and growth capital, buyout, and hedge fund investing. Ally Bridge Group focuses on both private and public equity investments, with a particular emphasis on pioneering life sciences companies and technologies. The firm is dedicated to bridging the gap between groundbreaking healthcare innovations and global markets. By leveraging its expertise and extensive network, Ally Bridge Group supports the growth and development of its portfolio companies. Its investment strategy is centered on transformative technologies and solutions that address major unmet medical needs.

Ally Bridge MedAlpha US Fund

Hong Kong

Hong Kong Island

Asia

The Week’s 10 Biggest Funding Rounds: Space Tech Startup Astranis Tops List

INSIGHTEC ANNOUNCES $150M FINANCING TO FUND CONTINUED GROWTH

Transcarent banks $126M Series D round as it puts focus on AI

India

T. Rowe Price Associates is a global investment management firm that provides a range of mutual funds, subadvisory services, and separate account management for individuals, institutions, retirement plans, and financial intermediaries.

T. Rowe Price Associates

Janus Henderson Investors is a leading global active asset manager dedicated to helping investors achieve long-term financial goals through a diverse range of investment solutions.

Janus Henderson Investors

RA Capital Management is a crossover investment manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices, and diagnostics.

RA Capital Management

OrbiMed is a leading investment firm dedicated exclusively to the healthcare sector, with approximately $18 billion in assets under management.

OrbiMed

Surveyor Capital is a global, multi-manager investment organization that invests in a wide range of industries, including healthcare, technology, and consumer sectors.

Surveyor Capital

Medicxi is a European life sciences-focused investment firm that provides capital and expertise to build early-stage and late-stage companies.

Medicxi

Logos Capital is an investment firm that focuses on providing strategic funding and guidance to innovative companies in the healthcare and life sciences sectors.

Logos Capital

Ally Bridge Group is a global healthcare investment firm that specializes in providing strategic funding and guidance to innovative companies in the life sciences and healthcare sectors. The firm focuses on creating value for its portfolio companies through its extensive network, deep industry expertise, and collaborative approach to investments.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	May 9, 2024 5:49 AM	0eccb285
public peers	general	May 9, 2024 5:49 AM	faf30608
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	May 9, 2024 5:49 AM	6687a62f
company summary	general
signals	general
crunchbase trigger	general	Nov 22, 2024 7:44 AM	6ccc4d76
crunchbase profile	general	Nov 22, 2024 9:27 AM	f3b3e15b
li profile	general	May 9, 2024 5:49 AM	73b9717b
translate crunchbase fundingrounds	general	Nov 22, 2024 3:53 PM	2da1c413
peers	general
news basic	general	May 9, 2024 5:49 AM	64e09781
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:ALLY-BRIDGE

Ally Bridge Group